Pseudomonas
Cystic Fibrosis Foundation Invests $2.3M in Owlstone Medical
The firm will develop an assay to detect and monitor Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Rhode Island Hospital Wins $1M From CARB-X for Molecular Pneumonia Blood Test
The funding supports proof-of-concept studies of a direct-from-blood PCR test informed by RNA sequencing to detect pneumonia-causing bacteria.
Curetis Receives €350K German Government Grant to Develop Carbapenem Resistance Test
The project, coordinated by Jena University Hospital and expected to run for five years, aims to address resistance mechanisms in Gram-negative pathogens.
IDbyDNA, Locus Biosciences Partner on CDx for CRISPR Antimicrobial
The next-generation sequencing test will be used to select patients for a clinical trial of Locus' Pseudomonas aeruginosa antimicrobial product.